News about Global Pharma

Kincell Bio Welcomes Larry Pitcher as Chief Operating Officer

Most recently, Larry was VP and GM for Catalent’s Gene Therapy Sites in MD, their largest operation, which accounted for a significant share of the company’s annual revenue.

Global Pharma | 19/03/2025 | By Aishwarya |  215

Shilpa Biologicals, mAbTree Biologics to Develop Immuno-Oncology Therapy

Under the terms of the agreement, Shilpa Biologicals will support the entire development process, including first-in-human clinical trials, while also ensuring long-term commercial supply through its Good Manufacturing Practice (GMP) manufacturing capabilities.

Global Pharma | 19/03/2025 | By Aishwarya |  574

Delpharm to Advance its Sterile Injectable Manufacturing Facility in Boucherville

The signing of a 10-year agreement between Delpharm and Sandoz establishes a foundation for ensuring a stable and reliable supply of critical medicines for Canadians, thereby enhancing the country's healthcare autonomy amid global supply chain disruptions.

Global Pharma | 19/03/2025 | By Aishwarya |  294

TAF 2025 Calls for Stricter Laws to Curb Drug Counterfeiting

In a major push to protect India’s industries, stakeholders at the 6th edition of the Traceability and Authentication Forum (TAF 2025) called for stricter anti-counterfeiting laws and advanced traceability measures.

Global Pharma | 19/03/2025 | By Aishwarya |  283

Clario Acquires NeuroRx

Clario, a provider of endpoint data solutions to the clinical trial industry, announced they have acquired NeuroRx, a company in imaging analysis with expertise in multiple sclerosis.

Global Pharma | 18/03/2025 | By Manvi |  271

Chance Pharma Receives New Funding to Develop Innovative Inhalation Therapies

Chance Pharma operates state-of-the-art production facilities compliant with FDA and EMA quality standards, underscoring its strong capabilities in both R&D and manufacturing.

Global Pharma | 18/03/2025 | By Aishwarya |  204

AstraZeneca Signs License Deal with Alteogen for ALT-B4

Under the terms of the agreement, AstraZeneca will acquire worldwide rights to use ALT-B4 to develop and commercialise subcutaneous formulations of several oncology assets.

Global Pharma | 18/03/2025 | By Aishwarya |  524

Curia Plans Expansion to Global Network of Sterile Fill-Finish Sites

Curia’s sterile fill-finish facility in Glasgow will add an integrated, isolator-based vial filling line and lyophilizer suitable for a broad range of drug product including highly potent capabilities, more than doubling current GMP batch size.

Global Pharma | 18/03/2025 | By Aishwarya |  616

Lupin Secures Tentative Approval from US FDA for Amifampridine Tablets

Lupin Ltd. has received tentative US FDA approval for its Amifampridine Tablets, 10 mg, a generic version of Firdapse, for treating Lambert-Eaton myasthenic syndrome.

Global Pharma | 17/03/2025 | By Manvi |  540

Avanos Medical Appoints David Pacitti as its New Chief Executive Officer

Avanos Medical, Inc. announced the appointment of David Pacitti as its new chief executive officer, effective April 14, 2025.

Global Pharma | 17/03/2025 | By Manvi |  344